What insulin resistance is, what drives it, the early signs, how it is evaluated, what actually improves it, and where supplementation reasonably fits.
By Dr. Nathan Riley, MD · Published April 12, 2026 · Updated April 24, 2026
Insulin resistance is the underlying physiological state behind prediabetes, type 2 diabetes, polycystic ovary syndrome, non-alcoholic fatty liver disease, and much of what is now called metabolic syndrome. It is common, progressive, and largely reversible in its earlier stages. Understanding what insulin resistance actually is — and what drives it — is the foundation for any sensible approach to metabolic health.
This guide covers what insulin resistance is in plain terms, how it progresses, the early signs worth watching for, the evidence-based approaches to improving it, and where supplementation reasonably fits in.
Insulin is a hormone produced by the beta cells of the pancreas. Its primary job is to move glucose from the bloodstream into the cells that need it, particularly muscle cells and fat cells. When you eat a meal containing carbohydrates, the glucose that results from digestion enters the bloodstream. The pancreas detects the rising glucose level and releases insulin. Insulin then binds to receptors on cell surfaces and signals those cells to pull glucose inside.
In a well-functioning system, a relatively small amount of insulin is enough to keep blood glucose in the normal range. The system is sensitive — a modest insulin signal produces a strong cellular response.
Insulin resistance is the state in which that cellular response becomes blunted. The cells need a larger insulin signal to produce the same glucose uptake. The pancreas, trying to maintain normal blood glucose, produces more insulin to compensate. For a while, this compensation works and blood glucose stays within the normal range. Insulin levels, however, are chronically elevated.
The causes of insulin resistance are multiple and overlapping. The most important drivers include:
Excess adipose tissue, particularly visceral fat. Fat that accumulates around abdominal organs is metabolically active and releases inflammatory signalling molecules that interfere with insulin signalling. This is a major reason why waist circumference is a more useful metabolic risk indicator than total body weight alone.
Chronic excess calorie intake, particularly from refined carbohydrates and added sugars. Frequent large glucose spikes over years gradually reduce insulin sensitivity.
Physical inactivity. Skeletal muscle is the major consumer of glucose in the body. Active muscle maintains strong insulin sensitivity; inactive muscle loses it. This is why exercise is one of the most powerful interventions for improving insulin sensitivity, often producing measurable improvements within days to weeks.
Poor sleep and circadian disruption. Even short-term sleep restriction demonstrably reduces insulin sensitivity in otherwise healthy adults. Shift workers and chronic poor sleepers have elevated rates of metabolic dysfunction.
Chronic stress and elevated cortisol. Cortisol actively opposes insulin's action in ways that are useful in acute situations but harmful when sustained.
Genetic susceptibility. Some adults develop insulin resistance earlier or more severely than others with identical lifestyle profiles. This is not an excuse for fatalism — the modifiable factors still matter — but it does inform how aggressive the intervention needs to be.
Insulin resistance is often silent in its early stages. Blood glucose can still appear normal because the pancreas is compensating. Subtle indicators that something may be off include:
None of these individually confirms insulin resistance, but together they raise the probability enough to warrant laboratory evaluation.
Standard assessment of insulin resistance and glucose metabolism includes fasting glucose, HbA1c, fasting insulin, and a lipid panel. A calculated index called HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) uses fasting glucose and fasting insulin together to estimate insulin resistance. Values above 2.5 typically suggest insulin resistance; values above 5 suggest significant resistance.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) provides patient-oriented background on insulin resistance, its relationship to prediabetes, and diagnostic considerations.
The interventions with the clearest evidence, in approximate order of effect size:
Resistance training and regular aerobic exercise. A combination of both appears to produce larger improvements in insulin sensitivity than either alone. Effects can appear within two to four weeks of consistent training and can double or triple within months.
Modest weight loss, particularly if visceral fat decreases. A 7 to 10 percent reduction in body weight often produces substantial improvements in insulin sensitivity. This is the target that drove the major effect size in the Diabetes Prevention Program.
Dietary reduction in refined carbohydrates and added sugars. This does not require a ketogenic diet for everyone — it requires reducing the glucose load that chronically stresses the insulin system. Fiber-rich whole-food carbohydrates replace refined options.
Sleep optimisation. Seven to nine hours per night, consistent timing, minimised late-night screen exposure. Less glamorous than diet or exercise but substantively powerful.
Stress management. Whatever form works — meditation, therapy, walking in nature, meaningful social connection. Chronic cortisol elevation opposes insulin signalling.
Pharmacological intervention when appropriate. Metformin remains the standard first-line medication and has a well-documented insulin-sensitising effect.
Multi-ingredient supplements like GlycoCare that provide chromium, magnesium, alpha lipoic acid, botanical extracts, and antioxidants have research-backed ingredient profiles for metabolic support. The cumulative effect for an adult doing the lifestyle work alongside supplementation is likely additive rather than transformative — useful but secondary to the primary interventions.
The pragmatic approach is to treat supplementation as support for the metabolic work, not a substitute. An adult meaningfully addressing diet, exercise, sleep, and stress may find daily multi-ingredient blood sugar support helpful as one layer among many. An adult hoping a daily capsule will allow them to skip the rest is likely to be disappointed in both the glycaemic outcome and the broader metabolic trajectory.
Insulin resistance is the common physiological substrate beneath a large portion of modern metabolic disease. It develops slowly, often silently, through modifiable drivers that include diet, activity, sleep, and stress. It is largely reversible in its earlier stages through evidence-aligned lifestyle change, sometimes supplemented by medication or adjunct botanical and nutritional support. Any serious approach begins with understanding the condition, confirming the diagnosis, addressing the primary drivers, and using supplementation as complementary rather than lead intervention.
This article is for educational purposes only and is not medical advice. Always consult your physician before starting any supplement, particularly if you have diabetes, prediabetes, hypoglycemia, or take any prescription medication for blood sugar control. Individual response varies. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA.